SARI, S. Et Al. 2016. New (arylalkyl)azole derivatives showing anticonvulsant effects could have VGSC and/or GABA(A)R affinity according to molecular modeling studies. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.124 , 407-416.

SARI, S., KARAKURT, A., USLU, H., KAYNAK, F. B., Calis, U., & DALKARA, S., (2016). New (arylalkyl)azole derivatives showing anticonvulsant effects could have VGSC and/or GABA(A)R affinity according to molecular modeling studies. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.124, 407-416.

SARI, SUAT Et Al. "New (arylalkyl)azole derivatives showing anticonvulsant effects could have VGSC and/or GABA(A)R affinity according to molecular modeling studies," EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.124, 407-416, 2016

SARI, SUAT Et Al. "New (arylalkyl)azole derivatives showing anticonvulsant effects could have VGSC and/or GABA(A)R affinity according to molecular modeling studies." EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.124, pp.407-416, 2016

SARI, S. Et Al. (2016) . "New (arylalkyl)azole derivatives showing anticonvulsant effects could have VGSC and/or GABA(A)R affinity according to molecular modeling studies." EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.124, pp.407-416.

@article{article, author={SUAT SARI Et Al. }, title={New (arylalkyl)azole derivatives showing anticonvulsant effects could have VGSC and/or GABA(A)R affinity according to molecular modeling studies}, journal={EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY}, year=2016, pages={407-416} }